Priority-setting criteria for clinical practice guideline development on rare genetic neurodevelopmental disorders: a Delphi study within the European Reference Network (ERN) ITHACA.
Mirthe Jasmijn Klein Haneveld, Michiel Sebastiaan Oerbekke, Katalin Szakszon, Martina Cornelia Cornel, Charlotte Maria Wilhelmina Gaasterland, Agnies Marguerite Van Eeghen
{"title":"Priority-setting criteria for clinical practice guideline development on rare genetic neurodevelopmental disorders: a Delphi study within the European Reference Network (ERN) ITHACA.","authors":"Mirthe Jasmijn Klein Haneveld, Michiel Sebastiaan Oerbekke, Katalin Szakszon, Martina Cornelia Cornel, Charlotte Maria Wilhelmina Gaasterland, Agnies Marguerite Van Eeghen","doi":"10.1016/j.jclinepi.2025.111761","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The prioritization of clinical practice guideline (CPG) efforts is particularly challenging for rare genetic neurodevelopmental disorders given the large number of (ultra)rare conditions and limited resources. We aimed to establish criteria for the priority-setting of CPG topics within the European Reference Network (ERN) ITHACA (Intellectual disability, TeleHealth, Autism and Congenital Anomalies) based on stakeholder input.</p><p><strong>Study design and setting: </strong>Sets of priority-setting criteria for aetiology-specific CPGs and shared health topic CPGs (across aetiologies) were generated using a two-phase consensus process. The first phase consisted of initial criteria generation, internal feedback from the ERN-ITHACA Executive Committee and Patient Advisory Board, and stakeholder input through an open survey. The second phase consisted of a two-round modified Delphi and consensus meeting with an expert panel consisting of patient advocates, clinicians, and methodologists.</p><p><strong>Results: </strong>The final sets of priority-setting criteria included absence of existing guidance, high burden for affected individuals and families, and specific health risks requiring adaptation from usual care. Additionally, complexity and treatment availability were included for aetiology-specific CPGs and common occurrence and societal burden were included for CPGs for shared health topics. Availability and interest of clinical experts and patient organizations were considered required to produce CPGs; shared health topics addressed through dedicated CPGs need to be universal across aetiologies.</p><p><strong>Conclusion: </strong>Aligning with stakeholder perspectives in priority-setting is required to allocate scarce resources to the development of high-priority CPGs for rare conditions. Priority-setting criteria specific to the rare condition context were identified. CPG development was considered a particular priority important for complex conditions and/or healthcare and where care is non-standard. Practice variation was not selected as a priority-setting criterion.</p>","PeriodicalId":51079,"journal":{"name":"Journal of Clinical Epidemiology","volume":" ","pages":"111761"},"PeriodicalIF":7.3000,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Epidemiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jclinepi.2025.111761","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: The prioritization of clinical practice guideline (CPG) efforts is particularly challenging for rare genetic neurodevelopmental disorders given the large number of (ultra)rare conditions and limited resources. We aimed to establish criteria for the priority-setting of CPG topics within the European Reference Network (ERN) ITHACA (Intellectual disability, TeleHealth, Autism and Congenital Anomalies) based on stakeholder input.
Study design and setting: Sets of priority-setting criteria for aetiology-specific CPGs and shared health topic CPGs (across aetiologies) were generated using a two-phase consensus process. The first phase consisted of initial criteria generation, internal feedback from the ERN-ITHACA Executive Committee and Patient Advisory Board, and stakeholder input through an open survey. The second phase consisted of a two-round modified Delphi and consensus meeting with an expert panel consisting of patient advocates, clinicians, and methodologists.
Results: The final sets of priority-setting criteria included absence of existing guidance, high burden for affected individuals and families, and specific health risks requiring adaptation from usual care. Additionally, complexity and treatment availability were included for aetiology-specific CPGs and common occurrence and societal burden were included for CPGs for shared health topics. Availability and interest of clinical experts and patient organizations were considered required to produce CPGs; shared health topics addressed through dedicated CPGs need to be universal across aetiologies.
Conclusion: Aligning with stakeholder perspectives in priority-setting is required to allocate scarce resources to the development of high-priority CPGs for rare conditions. Priority-setting criteria specific to the rare condition context were identified. CPG development was considered a particular priority important for complex conditions and/or healthcare and where care is non-standard. Practice variation was not selected as a priority-setting criterion.
期刊介绍:
The Journal of Clinical Epidemiology strives to enhance the quality of clinical and patient-oriented healthcare research by advancing and applying innovative methods in conducting, presenting, synthesizing, disseminating, and translating research results into optimal clinical practice. Special emphasis is placed on training new generations of scientists and clinical practice leaders.